Fortis Healthcare Share Price
- Advice
- Hold
Start SIP in Fortis Healthcare
Start SIPFortis Healthcare Performance
Day Range
- Low 589
- High 623
52 Week Range
- Low 314
- High 623
- Open Price592
- Previous Close591
- Volume2310188
Fortis Healthcare Investment Rating
-
Master Rating:
-
Fortis Healthcare (Nse) has an operating revenue of Rs. 7,094.41 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 12% is healthy, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 13% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 15% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 102 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 333 | 307 | 291 | 294 | 289 | 277 |
| Operating Expenses Qtr Cr | 275 | 238 | 242 | 255 | 254 | 250 |
| Operating Profit Qtr Cr | 58 | 69 | 49 | 40 | 35 | 28 |
| Depreciation Qtr Cr | 26 | 26 | 25 | 25 | 25 | 29 |
| Interest Qtr Cr | 17 | 18 | 19 | 21 | 23 | 25 |
| Tax Qtr Cr | 24 | 21 | 13 | 8 | 5 | 1 |
| Net Profit Qtr Cr | 27 | 68 | 23 | 95 | 13 | 2 |
Fortis Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹564.76
- 50 Day
- ₹533.47
- 100 Day
- ₹502.16
- 200 Day
- ₹460.09
- 20 Day
- ₹563.33
- 50 Day
- ₹525.30
- 100 Day
- ₹494.22
- 200 Day
- ₹456.16
Fortis Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 600.75 |
| Second Resistance | 611.00 |
| Third Resistance | 623.75 |
| RSI | 65.46 |
| MFI | 65.07 |
| MACD Single Line | 17.79 |
| MACD | 20.00 |
| Support | |
|---|---|
| First Support | 577.75 |
| Second Support | 565.00 |
| Third Supoort | 554.75 |
Fortis Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,243,626 | 59,644,303 | 47.96 |
| Week | 1,039,627 | 46,377,760 | 44.61 |
| 1 Month | 1,633,032 | 71,477,811 | 43.77 |
| 6 Month | 1,718,822 | 105,140,323 | 61.17 |
Fortis Healthcare Result Highlights
Fortis Healthcare Synopsis
NSE-Medical-Hospitals
Fortis Healthcare is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 1181.42 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2024. Fortis Healthcare Ltd. is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933.| Market Cap | 44,580 |
| Sales | 1,226 |
| Shares in Float | 52.09 |
| No of funds | 335 |
| Yield | 0.17 |
| Book Value | 4.91 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 3 |
| Alpha | 0.18 |
| Beta | 0.53 |
Fortis Healthcare Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% |
| Mutual Funds | 27.52% | 26.51% | 25.04% | 22.5% |
| Insurance Companies | 3.37% | 3.32% | 3.12% | 2.8% |
| Foreign Portfolio Investors | 23.31% | 23.24% | 23.72% | 26.31% |
| Financial Institutions/ Banks | 1.3% | 1.19% | 0.01% | 1.19% |
| Individual Investors | 10.47% | 10.81% | 11.04% | 11.13% |
| Others | 2.86% | 3.76% | 5.9% | 4.9% |
Fortis Healthcare Management
| Name | Designation |
|---|---|
| Mr. Ravi Rajagopal | Chairperson & Independent Director |
| Dr. Ashutosh Raghuvanshi | Managing Director & CEO |
| Ms. Suvalaxmi Chakraborty | Independent Director |
| Mr. Indrajit Banerjee | Independent Director |
| Ms. Shailaja Chandra | Independent Director |
| Mr. Tomo Nagahiro | Non Executive Director |
| Mr. Dilip Kadambi | Non Executive Director |
| Mr. Lim Tsin Lin | Non Executive Director |
| Mr. Mehmet Ali Aydinlar | Non Executive Director |
| Dr. Prem Kumar Nair | Non Executive Director |
| Mr. Ashok Pandit | Non Executive Director |
Fortis Healthcare Forecast
Price Estimates
Fortis Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-30 | To consider Fund Raising | |
| 2024-08-06 | Quarterly Results | |
| 2024-05-23 | Audited Results & Final Dividend | |
| 2024-02-07 | Quarterly Results | |
| 2023-11-10 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-24 | FINAL | Rs.1.00 per share(10%)Final Dividend |
| 2023-07-20 | FINAL | Rs.1.00 per share(10%)Final Dividend |
Fortis Healthcare FAQs
What is Share Price of Fortis Healthcare ?
Fortis Healthcare share price is ₹600 As on 20 September, 2024 | 13:16
What is the Market Cap of Fortis Healthcare ?
The Market Cap of Fortis Healthcare is ₹45297.5 Cr As on 20 September, 2024 | 13:16
What is the P/E ratio of Fortis Healthcare ?
The P/E ratio of Fortis Healthcare is 69.4 As on 20 September, 2024 | 13:16
What is the PB ratio of Fortis Healthcare ?
The PB ratio of Fortis Healthcare is 5.3 As on 20 September, 2024 | 13:16